AstraZeneca signs MoU with RSSDI to help 1 crore diabetic patients by 2023
AstraZeneca India, a biopharmaceutical company, signed a memorandum of understanding with the Research Society for Study of Diabetes in India (RSSDI)28-11-2020
28-11-2020
COVID-19 update | Philippines, private firms to sign vaccine supply deal with AstraZeneca
The private firms will pay for the vaccine and donate half of the supply to the government, with the other half to be used to cover employees in the private sector, Concepcion said, without identifying the private companies.27-11-2020
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith Certificate dated November 3, 2020 issued by Integrated Registry Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018.26-11-2020
Thailand to sign vaccine agreement with Oxford-AstraZeneca: PM Prayuth Chan-ocha
Southeast Asia's second-largest economy has kept total coronavirus cases at a low 3,942, with 60 deaths, but its ban on commercial flights imposed in April has battered its important tourism industry and slowed recovery efforts.26-11-2020
India Coronavirus Dispatch: How do you vaccinate a billion people?
AstraZeneca's manufacturing error, lack of transparency in Indian vaccine trials, should Indian states consider lockdowns again?-news relevant to India's fight against Covid-1926-11-2020
AstraZeneca must prove it won't profit from Covid-19 vaccine: Non-govt body
The price of its candidate has been set at about $3 per dose, against at least four times more for other candidates24-11-2020
Russian COVID-19 vaccine shows 90% efficacy; to be priced under $20
The announcement that comes a day after Oxford-Astrazeneca announced a similar level of efficacy for its COVID-19 vaccine allows India to hope for two vaccines to fight the COVID-19 pandemic in the country24-11-2020
COVID-19 vaccine | Serum Institute can apply for emergency use if AstraZeneca gets UK nod, says Dr Guleria
If the vaccine is approved by the UK authorities, Serum Institute could also apply for emergency use in India based on the same data, Dr Guleria, a member of the Centre's task force on vaccines, has said.24-11-2020
Oxford COVID-19 vaccine: India may grant SII emergency authorisation if AstraZeneca gets UK govt's nod
"We expect emergency authorisation for Oxford-Astrazeneca vaccine to be sought in the UK. If so, it will give an opportunity for India regulator also (to consider such an option)", says Dr Vinod Paul, chairman of the National Expert Group on Vaccine Administration for COVID-1921-11-2020
ASTRAZENECA PHARMA INDIA LTD. - 506820 - Disclosure Of Related Party Transactions
Pursuant to the provisions of Regulation 23 (9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 as amended, we enclose herewith the disclosure of Related Party Transactions for half year ended September 30, 2020 for your information and records.20-11-2020